We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genzyme Turns to AskBio to Boost Gene Therapy Development
Genzyme Turns to AskBio to Boost Gene Therapy Development
July 16, 2013
Asklepios BioPharmaceutical (AskBio) said Tuesday it has entered into a cross-licensing agreement with Genzyme in which each side gets access to the other’s gene therapy technology.